Login to MyKarger

New to MyKarger? Click here to sign up.

Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Clinical Thyroidology / Original Paper

Free Access

Standardized Ultrasound Report for Thyroid Nodules: The Endocrinologist's Viewpoint

Andrioli M.a · Carzaniga C.a · Persani L.a, b

Author affiliations

aDivision of Endocrine and Metabolic Diseases, San Luca Hospital, Istituto Auxologico Italiano, and bDipartimento di Scienze Cliniche e di Comunità, Università degli Studi di Milano, Milan, Italy

Corresponding Author

Massimiliano Andrioli, MD, PhD or Luca Persani, MD, PhD

Ospedale San Luca, IRCCS

Istituto Auxologico Italiano, P. le Brescia 20

IT-20149 Milan (Italy)

E-Mail massimoandrioli@endocrinologiaoggi.it or luca.persani@unimi.it

Related Articles for ""

Eur Thyroid J 2013;2:37-48

Do you have an account?

Login Information

Contact Information

I have read the Karger Terms and Conditions and agree.


Background: Ultrasonography (US) plays a crucial role in the diagnostic management of thyroid nodules, but its widespread use in clinical practice might generate heterogeneity in ultrasound reports. Objectives: The aims of the study were to propose (a) a standardized lexicon for description of thyroid nodules in order to reduce US reports of interobserver variability and (b) a US classification system of suspicion for thyroid nodules in order to promote a uniform management of thyroid nodules. Methods: Relevant published articles were identified by searching MEDLINE at PubMed combining the following search terms: ultrasonography, thyroid, nodule, malignancy, carcinoma, and classification system. Results were supplemented with our data and experience. Results: A standardized US report should always document position, extracapsular relationships, number, and the following characteristics of each thyroid lesion: shape, internal content, echogenicity, echotexture, presence of calcifications, margins, vascularity, and size. Combining the previous US features, each thyroid nodule can be tentatively classified as: malignant, suspicious for malignancy, borderline, probably benign, and benign. Conclusions: We propose a standardized US report and a tentative US classification system that may become helpful for endocrinologists dealing with thyroid nodules in their clinical practice. The proposed classification does not allow to bypass the required cytological confirmation, but may become useful in identifying the lesions with a lower risk of neoplasm.

© 2013 European Thyroid Association

Article / Publication Details

First-Page Preview
Abstract of Clinical Thyroidology / Original Paper

Received: November 27, 2012
Accepted: January 16, 2013
Published online: February 22, 2013
Issue release date: March 2013

Number of Print Pages: 12
Number of Figures: 1
Number of Tables: 1

ISSN: 2235-0640 (Print)
eISSN: 2235-0802 (Online)

For additional information: http://www.karger.com/ETJ

Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.